Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

NCT05276973

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
Locations
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details
Active, Not Recruiting

A Trial of Vigil for Participants With Ovarian Cancer

NCT02346747

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Southern California Permanente Medical Group Irvine, California, United States
  • Palo Alto Foundation Medical Group San Francisco, California, United States
  • University Of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

NCT05456685

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center /ID# 268906 Tucson, Arizona, United States
  • Women'S Cancer Research Network - Cogi /ID# 268912 Fresno, California, United States
  • Providence - St. Jude Medical /ID# 268911 Fullerton, California, United States
  • Moores Cancer Center /ID# 268888 La Jolla, California, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

A Study of Sovilnesib in Subjects With Ovarian Cancer

NCT06084416

Conditions
Adnexal Diseases, Chromosomal Instability, Chromosome Aberrations, +17 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 13 locations
View Trial Details

Related conditions